Open AccessThe clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients
Author(s) -
Huijuan Li,
Yangyang Xu,
Bing Wan,
Yong Song,
Ping Zhan,
Yangbo Hu,
Qun Zhang,
Fang Zhang,
Hongbing Liu,
Tianhong Li,
Haruhiko Sugimura,
Federico Cappuzzo,
Dongxin Lin,
Tangfeng Lv
Publication year - 2019
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2019.08.04
Subject(s) - medicine , hazard ratio , immunohistochemistry , lung cancer , confidence interval , meta analysis , subgroup analysis , odds ratio , oncology , stage (stratigraphy) , gastroenterology , cochrane library , pathology , paleontology , biology
We conducted a meta-analysis to systematically evaluate the relationship between programmed death-ligand 1 (PD-L1) expression and survival in patients with lung cancer.